A.P. Carvalho

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Rami Kantor, David Katzenstein, Brad Efron et al. · PLoS Medicine · 2005 · 318 citations · Full text

Life Sciences, Molecular Genetics, Molecular Epidemiology +14

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Joke Snoeck, Rami Kantor, Robert W. Shafer et al. · Antimicrobial Agents and Chemotherapy · 2006 · 90 citations · Full text

Life Sciences, Molecular Genetics, Pharmacology +17

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G

Ana Abecasis, Koen Deforche, Joke Snoeck et al. · AIDS · 2005 · 85 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier.

Maria S. Santos, Fernanda M. Ferreira, A. Proença da Cunha et al. · PubMed · 1994 · 75 citations

Life Sciences, Neuroscience, Pharmacology +17

Investigation of Baseline Susceptibility to Protease Inhibitors in HIV-1 Subtypes C, F, G and Crf02_Ag

Ana Abecasis, Koen Deforche, Lee T. Bacheler et al. · Antiviral Therapy · 2006 · 71 citations · Full text

Life Sciences, Infectious Diseases, Molecular Virology +16